These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 28711857)
1. Methotrexate-F127 conjugated mesoporous zinc hydroxyapatite as an efficient drug delivery system for overcoming chemotherapy resistance in osteosarcoma cells. Meshkini A; Oveisi H Colloids Surf B Biointerfaces; 2017 Oct; 158():319-330. PubMed ID: 28711857 [TBL] [Abstract][Full Text] [Related]
3. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy. Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845 [TBL] [Abstract][Full Text] [Related]
4. pH- and thermo-sensitive MTX-loaded magnetic nanocomposites: synthesis, characterization, and in vitro studies on A549 lung cancer cell and MR imaging. Farshbaf M; Salehi R; Annabi N; Khalilov R; Akbarzadeh A; Davaran S Drug Dev Ind Pharm; 2018 Mar; 44(3):452-462. PubMed ID: 29098882 [TBL] [Abstract][Full Text] [Related]
5. A novel platform designed by Au core/inorganic shell structure conjugated onto MTX/LDH for chemo-photothermal therapy. Tian DY; Wang WY; Li SP; Li XD; Sha ZL Int J Pharm; 2016 May; 505(1-2):96-106. PubMed ID: 26997424 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Kohler N; Sun C; Wang J; Zhang M Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971 [TBL] [Abstract][Full Text] [Related]
7. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity. Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427 [TBL] [Abstract][Full Text] [Related]
8. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment. Abbasi Aval N; Pirayesh Islamian J; Hatamian M; Arabfirouzjaei M; Javadpour J; Rashidi MR Int J Pharm; 2016 Jul; 509(1-2):159-167. PubMed ID: 27234695 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate Gold Nanocarriers: Loading and Release Study: Its Activity in Colon and Lung Cancer Cells. Álvarez-González B; Rozalen M; Fernández-Perales M; Álvarez MA; Sánchez-Polo M Molecules; 2020 Dec; 25(24):. PubMed ID: 33371436 [TBL] [Abstract][Full Text] [Related]
10. Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug. Prasad SR; Kumar TSS; Jayakrishnan A Nanotechnology; 2018 Jan; 29(1):015101. PubMed ID: 29130895 [TBL] [Abstract][Full Text] [Related]
11. Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers. Prasad SR; Jayakrishnan A; Kumar TSS J Mater Sci Mater Med; 2020 May; 31(5):44. PubMed ID: 32367204 [TBL] [Abstract][Full Text] [Related]
12. A biodegradable pH and glutathione dual-triggered drug delivery system based on mesoporous silica, carboxymethyl chitosan and oxidized pullulan. Rui Q; Gao J; Yin ZZ; Li J; Cai W; Wu D; Kong Y Int J Biol Macromol; 2023 Jan; 224():1294-1302. PubMed ID: 36306897 [TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor efficacy by methotrexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancer. Chen Y; Zhang W; Gu J; Ren Q; Fan Z; Zhong W; Fang X; Sha X Int J Pharm; 2013 Aug; 452(1-2):421-33. PubMed ID: 23688623 [TBL] [Abstract][Full Text] [Related]
14. "Watson-Crick G[triple bond, length as m-dash]C"-inspired supramolecular nanodrug of methotrexate and 5-fluorouracil for tumor microenvironment-activatable self-recognizing synergistic chemotherapy. Chen M; Chen S; Zhu F; Wang F; Tian H; Fan Z; Ke S; Hou Z; Li Y J Mater Chem B; 2020 May; 8(17):3829-3841. PubMed ID: 32232285 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional nanospheres for co-delivery of methotrexate and mild hyperthermia to colon cancer cells. Costa Lima SA; Gaspar A; Reis S; Durães L Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():1420-1426. PubMed ID: 28415433 [TBL] [Abstract][Full Text] [Related]
16. Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate-mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects. Fan Z; Wang Y; Xiang S; Zuo W; Huang D; Jiang B; Sun H; Yin W; Xie L; Hou Z J Mater Chem B; 2020 Mar; 8(9):1922-1934. PubMed ID: 32052817 [TBL] [Abstract][Full Text] [Related]
17. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma. Li S; Xiong Y; Zhang X Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430 [TBL] [Abstract][Full Text] [Related]
18. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
19. Zinc Oxide Nanoparticles as Adjuvant To Facilitate Doxorubicin Intracellular Accumulation and Visualize pH-Responsive Release for Overcoming Drug Resistance. Liu J; Ma X; Jin S; Xue X; Zhang C; Wei T; Guo W; Liang XJ Mol Pharm; 2016 May; 13(5):1723-30. PubMed ID: 27070828 [TBL] [Abstract][Full Text] [Related]
20. A micelle-like structure of poloxamer-methotrexate conjugates as nanocarrier for methotrexate delivery. Ren J; Fang Z; Yao L; Dahmani FZ; Yin L; Zhou J; Yao J Int J Pharm; 2015 Jun; 487(1-2):177-86. PubMed ID: 25865570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]